Literature DB >> 3500676

Fibronectin and immune complexes in rheumatic diseases.

K E Herbert1, J S Coppock, A M Griffiths, A Williams, M W Robinson, D L Scott.   

Abstract

The relation between fibronectin and immune complexes in rheumatic disease was examined in a series of linked studies. Fibronectin was present in immune complexes formed in vitro in the absence of C1q. Gel filtration chromatography showed complexed fibronectin was present in the serum of a patient with rheumatoid vasculitis, but not in normal serum; the complexed fibronectin coeluted with IgA and C3. Two dimensional immunoelectrophoresis showed a single fibronectin component was present in normal serum, but a number of components were present in serum from a rheumatoid patient. Polyacrylamide gel electrophoresis followed by immunoblotting for fibronectin showed that polyethylene glycol precipitates of synovial fluid contained immunoreactive components of a variety of sizes, indicating the presence of fragments of the molecule. An analysis of fibronectin in polyethylene glycol precipitates of paired serum and synovial fluid samples from 17 patients with rheumatoid arthritis and 16 with osteoarthritis showed more fibronectin was present in rheumatoid samples, especially in synovial fluid. More fibronectin was also present in synovial fluid than in serum polyethylene glycol precipitates; there was no direct relationship with C1q levels. All these results suggest that fibronectin is an integral component of immune complexes. This has potential pathogenic significance because it shows that a product of connective tissue cells may influence the functions of the immune system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500676      PMCID: PMC1003379          DOI: 10.1136/ard.46.10.734

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  Purification of opsonically active human and rat cold-insoluble globulin (plasma fibronectin).

Authors:  J Molnar; F B Gelder; M Z Lai; G E Siefring; R B Credo; L Lorand
Journal:  Biochemistry       Date:  1979-09-04       Impact factor: 3.162

Review 2.  Fibronectins--adhesive glycoproteins of cell surface and blood.

Authors:  K M Yamada; K Olden
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Quantitative immunoelectrophoresis of human serum proteins.

Authors:  H G Clarke; T Freeman
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

5.  Characterization of a major fibroblast cell surface glycoprotein.

Authors:  K M Yamada; D H Schlesinger; D W Kennedy; I Pastan
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

6.  Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule.

Authors:  M B Furie; D B Rifkin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

7.  Fibronectin.

Authors:  D F Mosher
Journal:  Prog Hemost Thromb       Date:  1980

Review 8.  The structure and biologic activities of plasma fibronectin.

Authors:  M W Mosesson; D L Amrani
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

9.  Destruction of a major extracellular adhesive glycoprotein (fibronectin) of human fibroblasts by neutral proteases from polymorphonuclear leukocyte granules.

Authors:  J A McDonald; B J Baum; D M Rosenberg; J A Kelman; S C Brin; R G Crystal
Journal:  Lab Invest       Date:  1979-03       Impact factor: 5.662

10.  Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Authors:  J S Coppock; D L Scott; S D Carter; T M Moreland; M W Robinson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

View more
  8 in total

1.  Synovial fluid fibronectin concentrations in chronic arthritis: influence of intra-articular steroids or oral non-steroidal anti-inflammatory drugs.

Authors:  R A Jacobs; K E Herbert; D L Scott
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Fibronectin and circulating immune complexes in Behet's disease.

Authors:  K Ozoran; N Düzgün; H Tutkak; A Gürler; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  VLA family in rheumatoid arthritis: evidence for in vivo regulated adhesion of synovial fluid T cells to fibronectin through VLA-5 integrin.

Authors:  R García-Vicuña; A Humbría; A A Postigo; C López-Elzaurdia; M O de Landázuri; F Sánchez-Madrid; A Laffón
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

5.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  What proteins are present in polyethylene glycol precipitates from rheumatic sera?

Authors:  M W Robinson; D G Scott; P A Bacon; K W Walton; J S Coppock; D L Scott
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

7.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

8.  Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.

Authors:  Joyce J B C van Beers; Annemiek Willemze; Judith Stammen-Vogelzangs; Jan W Drijfhout; René E M Toes; Ger J M Pruijn
Journal:  Arthritis Res Ther       Date:  2012-02-17       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.